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Abstract
Rheumatoid arthritis (RA), a chronic systemic inflammatory disorder that principally attacks synovial joints, afflicts over
2 million people in the United States. Interleukin (IL)-17 is considered to be a master cytokine in chronic, destructive
arthritis. Levels of the ganglioside GM3, one of the most primitive glycosphingolipids containing a sialic acid in the
structure, are remarkably decreased in the synovium of patients with RA. Based on the increased cytokine secretions
observed in in vitro experiments, GM3 might have an immunologic role. Here, to clarify the association between RA and
GM3, we established a collagen-induced arthritis mouse model using the null mutation of the ganglioside GM3 synthase
gene. GM3 deficiency exacerbated inflammatory arthritis in the mouse model of RA. In addition, disrupting GM3 induced T
cell activation in vivo and promoted overproduction of the cytokines involved in RA. In contrast, the amount of the GM3
synthase gene transcript in the synovium was higher in patients with RA than in those with osteoarthritis. These findings
indicate a crucial role for GM3 in the pathogenesis and progression of RA. Control of glycosphingolipids such as GM3 might
therefore provide a novel therapeutic strategy for RA.
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Introduction
Rheumatoid arthritis (RA) is an autoimmune disease charac-
terized by chronic inflammation of the synovial tissues in multiple
joints, leading to joint destruction [1]. The pathologic features of
RA include hyperplasia of the synovial lining cell layer; infiltration
of inflammatory cells in the subintima, comprising predominately
lymphocytes, plasma cells, and macrophages; and deposition of
fibrin on the synovial surfaces, especially in clinically active
disease. The pathogenesis of RA, however, is not fully understood.
CD4
+ T cells, key molecules in primary inflammatory lesions, have
an essential role in the initiation of subsequent inflammatory
responses [2]. In particular, Th17 cells (a subset of CD4
+ T cells
that are distinct from Th1 and Th2) and regulatory T cells are
suggested to mediate inflammation and thus have a key role in the
pathogenesis of RA [3]. Furthermore, interleukin (IL)-17, secreted
by Th17 cells, stimulates the production of IL-6, IL-1, tumor
necrosis factor (TNF)a, IL-8, matrix metalloproteinases, and other
proinflammatory factors [4]. The cytokine IL-17 enhances the
inflammation associated with RA and contributes to the patho-
genesis of RA by inducing monocyte migration into the inflamed
synovial tissue [5,6]. High-level production of proinflammatory
cytokines, such as IL-1 and TNFa, in the synovium results from an
interaction between monocytes or macrophage cells and synovio-
cytes [7]. The regulatory mechanism of Th17 cells in RA,
however, remains unclear.
Ganglioside GM3 and its derivatives (Figure 1) are membrane-
bound glycosphingolipids (GSLs) composed of an oligosaccharide
head structure containing one or more sialic acid residue [8].
GSLs act to transduce signals involved in cell surface events,
including the phosphorylation of transmembrane receptors [9].
GM3 is the most widely distributed ganglioside among tissues, and
serves as a precursor for most of the more complex ganglioside
species [10]. GM3 inhibits the function of fibroblast growth factor
receptor [11], and cell growth is regulated by GM3-enriched
microdomain [12]. GM3 is thought to inhibit immunologic
functions, such as the proliferation and production of cytokines
by T cells [13]. In contrast, higher levels of GM3 in lipid rafts
promote an increase in the T cell responsiveness to stimulation in
vitro [14]. Few studies, however, have assessed whether the
immunoreaction related to gangliosides occurs as a positive or
negative event in vivo. T cells are the predominant infiltrating
lymphocytes in the synovium of RA patients [15]. Thus, we
PLoS ONE | www.plosone.org 1 June 2012 | Volume 7 | Issue 6 | e40136hypothesized that GM3 is involved in the T cell mechanism of RA,
thereby contributing to the clinical features of RA. The aims of the
present study were to determine the relation betweenGM3 and the
pathogenesis or progression of RA, and to clarify the effect of
GM3 on Th17 cell proliferation and IL-17 secretion from Th17
cells using a mouse collagen-induced arthritis (CIA) model.
Results
GM3 is Increased in the Synovium of RA Patients
Infiltration of multi-stratified synoviocytes and inflammatory
cells into synovial tissues is commonly observed in RA patients
(Figure 2A). We used mass spectrometry to investigate the amount
of GSL in the synovium. The total GSL amount was slightly
decreased in RA patients (Figure 2B). The amount of GM3 in the
ganglioside synthetic pathway was decreased in the synovium of
RA patients compared to osteoarthritis (OA) patients (Figure 2C).
The relative amount of GM3 among GSLs was also lower in RA
patients than in OA patients (Figure 2C). In contrast to the
amount of GM3 production in the synovium, GM3 synthase
(GM3S) mRNA transcription was increased in the synovium and
in the peripheral blood mononuclear cells (PBMCs) of RA patients
(Figure 2D). These results suggest that GM3 may be involved in
the pathogenesis of RA.
Higher GM3 Synthase mRNA Gene Expression in CIA
To determine whether GM3 is involved in the pathogenesis of
RA, we selected a CIA model. The CIA model is a well-established
model suitable for extrapolation to human RA [16]. At 35 days
after immunization with chick collagen type II (CII), GM3S
mRNA transcription was increased in the synovial tissue and
spleen of CIA wild-type (WT) mice compared with naı ¨ve WT mice
(Figure 3). This finding suggests that inflammation derived from
CIA leads to an increase in GM3 synthase gene expression.
The Lack of GM3 Accelerates the Pathogenesis and
Severity of CIA
To investigate the relationship between GM3 and the de-
velopment of autoimmune arthritis, we used knockout mice with
Figure 1. Lactosylceramide (LacCer) is the key branching point of sphingolipid biosynthesis. In the synthetic pathway of sphingolipids,
four alternate pathways (lacto-series, neolacto-series, globo-series, and isoglobo-series) branch-off from LacCer. GM3S
2/2 mice, in which the GM3
synthase gene is disrupted, produced only o-series gangliosides, including GA2 and GA1, and not a-series or b-series gangliosides.
doi:10.1371/journal.pone.0040136.g001
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2/2
mice) [8]. The incidence of arthritis and arthritis scores of the
GM3S
2/2 mice were significantly greater than those of WT mice
(Figure 4A and B). Although the genetic background of the mice
influences the arthritis score (i.e., C57BL/6 is a low responder
strain for the CIA model [17]), GM3S
2/2 mice with a C57BL/6
genetic background had a greater response. Two weeks after
secondary immunization, morphologically progressive destruction,
synovial invasion, and a large number of inflammatory cells were
observed in the joint region in GM3S
2/2 mice. Based on the
histological scoring, GM3S
2/2 mice exhibited significantly worse
inflammation, synovial hypertrophy, and bone destruction com-
pared with WT mice (Figure 4C and D). At 25 days after
immunization, serum levels of IL-6 as an exacerbation factor of
RA, were significantly higher in GM3S
2/2 mice than in WT mice
(Figure 4E). CII-specific serum IgG2a levels at 35 days after
immunization were significantly higher in GM3S
2/2 mice than in
WT mice (Figure 4F). The onset was earlier in GM3S
2/2 mice
than in WT mice (Table 1). These results confirm that GM3
deficiency leads to the development of CIA, and accelerates the
pathogenesis of CIA.
GM3 Deficiency Promotes the Proliferation of Th17 Cells
in CIA Models
These suppressive roles of GM3 in the development of CIA
suggest that GM3 may be involved in CD4
+ T cell behaviors
because CD4
+ T cells are the predominant infiltrating lympho-
cytes in RA synovium [15]. Therefore, we investigated the T cell
proliferation in GM3S
2/2 CIA mice. Based on flow cytometry
analysis, the numbers of CD4
+/CD8
+ T, B220
+, and CD11b
+ cells
in the inguinal lymph nodes (iLNs) 1 week after CII stimulation
were not significantly different (Figure 5A). The ratio of Th17 cells
in CD4
+ T cells, on the other hand, was significantly increased in
GM3S
2/2 mice (Figure 5B). These findings suggest that the loss of
GM3 induces the proliferation of Th17 cells as a CD4
+ T cell
subset under CII stimulation.
Deletion of GM3 Promotes High Immunologic Response
of T Cells
To investigate the immunologic response of T cells by the
deletion of GM3 in vivo, anti-CD3 antibody was intraperitoneally
administered to mice and IL-17, IL-4, interferon (IFN) c, IL-6,
and TNFa levels in serum were measured. These cytokine levels
were higher in GM3S
2/2 mice than in WT mice (Figure 6). These
findings indicate that GM3 may act as a regulatory molecule to
suppress the immunologic response in CD4
+ T cells to stimulus of
T cell receptor antigen, thereby the lack of GM3 may lead to high
levels of cytokines, especially IL-17 secretion from Th17 cells.
Discussion
Gangliosides containing one or more sialic acid residues are
present in all mammalian cell plasma membranes and intracellular
membrane structures [18]. Gangliosides have essential roles in the
early development, cell differentiation, proliferation, and the
immune response [19]. GM3 is the most widely distributed
ganglioside among tissues, and serves as a precursor for most of the
more complex ganglioside species [10]. The role of GM3 in RA,
however, is not almost clear. In the present study, the total GSL
amount was slightly decreased in RA patients. The amount of
GM3, on the other hand, was significantly decreased in the
synovium of RA patients compared to OA patients. GSLs
comprise many derivatives starting from ceramide, and five
distinguishable synthetic pathways from lactosylceramide have
been confirmed (Figure 1). Therefore, it is reasonable that the total
GSL amount was not remarkably different, despite the fact that
GM3 alone was decreased in the synthetic pathways. In contrast,
GM3S mRNA transcription was increased in the synovium and in
the PBMCs of RA patients. Therefore, the amount of GM3
detected by mass spectrometry revealed a gap between GM3S
mRNA transcription and GM3 production. RA patients likely
have a mechanism to compensate for the lack of GM3.
Figure 2. Clinical features related to GM3 in patients with RA or OA. A. Histology of RA and OA patients. Hematoxylin and eosin (HE)
staining. Scale bars =200 mm. B. Quantification of total GSL glycans in human synovium (n =5 per group). C. Absolute and relative amounts of GM3
glycans in human synovium (n =5 per group). D. Quantification of GM3S mRNA in synovium and PBMCs in RA and OA patients (n =5 per group).
Data shown are mean 6 SEM. *P,0.05, compared to OA patients.
doi:10.1371/journal.pone.0040136.g002
Figure 3. Quantification of GM3S mRNA in synovial tissues and
spleens from C57BL/6 naı ¨ve and CIA mice. Mice were anesthe-
tized and killed on day 35 after CII-CFA stimulation and synovial tissues
and spleens were removed to analyze GM3S mRNA (n =5 per group).
A. mRNA in synovial tissue. B. mRNA in spleen. Data shown are mean 6
SEM. *P,0.05, compared with naı ¨ve WT mice.
doi:10.1371/journal.pone.0040136.g003
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development of autoimmune arthritis in a CIA model using
GM3S
2/2 mice. The development of CIA was significantly
higher in GM3S
2/2 mice. Th17 cells produce various cytokines
including IL-17. IL-17 has profound pro-inflammatory effects
and induces tissue damage during the course of various
autoimmune diseases, such as the CIA animal model [20,21].
Th17 cells are distinct from Th1, Th2, and regulatory T cells.
IL-17 causes cartilage and bone destruction in mice [22]. Mice
deficient in IL-17 are resistant to the pathogenesis and pro-
gression of CIA [1]. In humans, IL-17 directly causes cartilage
and bone destruction in RA patients [23]. IL-17 stimulates the
production of IL-6, TNFa, and other proinflammatory factors
[4]. The differentiation of Th17 cells is dependent on IL-6 [24].
IL-17 activates synovial fibroblasts and macrophages to stimulate
the production of IL-6 and TNFa, which lead to joint
inflammation [25,26]. In the present study, the ratio of Th17
cells in CIA was significantly higher in the iLN of GM3S
2/2
mice. Furthermore, serum IL-6 levels were significantly higher in
GM3S
2/2 mice. Our results are consistent with these previous
reports and suggest that the augmentation of Th17 cells in
GM3S
2/2 mice induces a greater increase in the serum IL-6
levels than in WT mice. Our findings that GM3S
2/2 mice
secrete more IL-17 under CIA stimulation are also consistent
with the fact that IL-17 is involved in the initiation and
progression of CIA, and that inhibition of IL-17 in a mouse CIA
model reduces inflammation and bone erosion [27,28]. Based on
these findings, GM3 suppresses the Th17 cell proliferation in
autoimmune arthritis. These findings confirm some previous
reports [13,29]. In contrast, however, higher levels of GM3 in
lipid rafts are reported to promote an increase in naı ¨ve T cell
responsiveness to stimulation in in vitro culture [14]. In the in vivo
Th-17 disease model, GM3S
2/2 mice had more severe arthritis
and expressed larger quantities of cytokines. Thus, it remains
unclear whether GM3 affects the disease pathogenesis. We could
not find previous studies according to the relation between GM3
and RA, and diseases which GM3 decreases. At the present time,
the mechanism accelerating the development of CIA by the
deletion of GM3 is unknown. However, based on our results, two
Figure 4. Phenotype of WT and GM3S
2/2 CIA mice. CIA was induced in C57BL/6 WT and GM3S
2/2 mice (10–15 weeks old). Mice were
immunized with chicken CII emulsified with CFA on days 0 and 21(n =17 WT and n =12 GM3S
2/2 mice). A. Cumulative incidence of arthritis. B.
Arthritis score with CII-CFA. C. Photomicrographs show HE-stained paraffin sections of the right hind limbs of naı ¨ve, CIA WT, and CIA GM3S
2/2 mice
at day 35 of the study. Scale bars =200 mm D. Histological scores on day 35 after primary immunization with CII-CFA (n =5 per group). E. Serum IL-6
levels in mice on day 25 after primary immunization with CII-CFA (n =5 per group). F. Serum levels of total IgG, IgG1, IgG2a, IgG2b, and IgG3 anti-
chicken CII antibodies with CII-CFA on day 35 after primary immunization (n =5 per group). Data shown are mean 6 SEM. *P,0.05, **P,0.01
compared to WT mice.
doi:10.1371/journal.pone.0040136.g004
Table 1. Onset of CIA from primary immunization.
WT GM3S
2/2
onset 31.661.8 26.760.7*
Data shown are mean 6 SEM. *P,0.05, compared to WT mice.
doi:10.1371/journal.pone.0040136.t001
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augmentation. Second factor is higher susceptibility to stimula-
tion of T cells, especially Th17 cells, due to GM3 deficiency in
a CIA model. To confirm this susceptibility, we investigated
whether GM3 is involved in the reaction to the T cell receptor
antigen, anti-CD3 antibody. The levels of IL-17, IL-4, IFNc, IL-
6, and TNFa in the serum were higher in GM3S
2/2 mice than
in WT mice. These findings suggest that GM3 is involved in the
T cell susceptibility to stimulation. By these reasons, it is possible
that IL-17 production and secretion are increase in a GM3
deficiency CIA model.
To our knowledge, this is the first study to show a relation
between GM3 and the pathogenesis and progression of RA and
CIA in vivo. The present findings indicate that GM3 may become
a regulatory molecule against the production and secretion of
cytokines, especially IL-17 derived from Th17 cells, which
contributes to the pathogenesis and progression of RA. RA
synovial fibroblasts are targeted by IL-17 in the joint synovium
[30]. IL-17 enhances the release of IL-6, which is a key
inflammatory cytokine in the joints [31,32]. We produced T
cell-specific knockout mice with a null mutation of the glucosyl-
ceramide synthase (Ugcg). The T cells in these mice do not contain
any GSL. We assessed serum IL-17 levels after administrating
anti-CD3 antibody and CIA severity. Serum IL-17 levels in T cell-
specific mice after administrating anti-CD3 antibody were almost
the same as those in GM3S
2/2 mice. Interestingly, the CIA
incidence and arthritis scores in GM3S
2/2 mice were very severe,
but the severity in T cell-specific mice was milder than that in
GM3S
2/2 mice (data not shown). Consequently, our results
suggest that GM3 may be involved not only in cytokine production
but also in the sensitivity of joint synovium.
In this study, there are some limitations. First, the mechanism
of developing CIA in GM3 deficiency is unknown. GSLs have
been implicated as inhibiting various signal transductions on cell
membranes [33]. As one of the possibility, GM3 may be involved
in inhibiting the signal transduction on Th17 cells in CIA.
Second, The relation between GM3 and cells except T cells
(macrophage, osteoclast, fibroblast, or synoviocyte and so on) in
CIA is not clear. To our knowledge, there are no reports of this
relation. Third, GM3S
2/2 mice have O-series gangliosides
different from a- or b-series gangliosides, and O-series ganglio-
sides may compensate for the complete absence of the products
of GM3S in GM3S
2/2 mice [34]. In the results from our MS
analysis, O-series gangliosides did not show the significant
increase of their amounts in synovium. It is a strong possibility
that another pathways (Lacto, Neolacto, Globo, and Neoglobo)
through the lactosylceramides may increase their products. Due
to the samples of gangliosides derived from fibroblast and
synovium, any products with abnormal structures which are not
normally expressed in wild type were not detected in synovium.
However, to do the complete detection of their products, we
should examine MS/MS analysis and more. We will investigate
the relation between o-series gangliosides and CIA, because O-
series gangliosides have the potential to make an effect on the
pathogenesis or progression of CIA in GM3S
2/2 mice. Finally,
we speculate that GM3 strongly participate in the pathogenesis
and progression of human RA. Further studies are required to
confirm our speculation.
In conclusion, our findings indicate that GM3 deletion
accelerates the pathogenesis and progression of RA and mouse
CIA by increasing IL-17 proliferation and secretion from Th17
cells. Based on these findings, we reasonably conclude that GM3
may act as a regulatory molecule to suppress the proliferation and
secretion of IL-17 from Th17 cells, thereby preventing the
pathogenesis and progression of RA and CIA. GM3 might
therefore be a factor for novel and effective strategies for the
treatment of RA.
Figure 5. Immune response of T cells in WT and GM3S
2/2 mouse CIA models. A. CD4
+, CD8
+, B220
+, and CD11b
+ T cell contents of iLNs in
WT and GM3S
2/2 mice on day 7 after immunization with CII-CFA (n =3 per group). B. The Th17 cell content in CD4
+ T cells in mouse iLNs (n =3 per
group). Data shown are mean 6 SEM. *P,0.05, compared to WT mice.
doi:10.1371/journal.pone.0040136.g005
Figure 6. T-cell immune response following anti-CD3 antibody stimulation. Serum levels of IL-17, IL-4, IFNc, IL-6, and TNFa at 1.5 h after
intraperitoneal administration of 20 mg anti-CD3 antibody (n =5 per group). Data shown are mean 6 SEM. *P,0.05, compared to WT mice.
doi:10.1371/journal.pone.0040136.g006
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Ethics Statement
Written informed consent was obtained from all the participants
after being approved by the Ethics Committee of the School of
Medicine, Hokkaido University (permit number: 008–0076). All
experimental protocols of mice were in compliance with the rules
and regulations of the Animal Care and Use Committee of
Hokkaido University (permit number: 23 (26) ). All experiments
were performed in Hokkaido University.
Patients
Synovium was obtained from five patients with RA and five
patients with OA undergoing total knee arthroplasty, and blood
was obtained from all patients during the postoperative period.
The RA patients fulfilled the criteria of the American College of
Rheumatology.
Mice
GM3 synthase knockout (GM3S
2/2) mice were generated as
described previously [8]. Male GM3S
2/2 mice (10–15 weeks old)
were backcrossed over 15 generations to C57BL/6 mice, and age-
matched male C57BL/6 wild-type (WT) mice were used as
a control.
Cell Preparation
PBMCs were isolated from the heparinized blood of patients
with RA or OA. The cells were collected using Ficoll-Paque (GE
Healthcare) density-gradient centrifugation. Spleens and iLNs in
mice were isolated and passed through cell strainers (BD Falcon) to
obtain single-cell suspensions. Red blood cells isolated from the
spleen were lysed by two consecutive incubations (5 and 3 minutes
at 37uC) in an NH4Cl suspension (0.83% in 0.01 M Tris-HCl,
pH 7.2). The remaining cells were washed. These cells were used
for real-time reverse transcription-polymerase chain reaction
(PCR) and flow cytometry.
RNA Isolation and Real-time Reverse Transcription-PCR
We isolated total RNA in the synovium and PBMCs from
humans, and synovial tissues and splenocytes in mice using Trizol
reagent and analyzed the RNA for GM3 synthase gene expression.
RNA expression was determined by absorbance at wavelengths of
260 nm and 280 nm. Total RNA (1 mg) was converted to cDNA
using ImPromIITM Reverse Transcriptase (Promega) according
to the manufacturer’s instructions. We performed quantitative
analysis of the mRNA levels using Opticon Real-time PCR (Bio-
Rad Laboratories) with sequence-specific primer pairs: human
GM3S; (59-39) GAACTCTTGCCAGAGCACGA (39-59)
GACGTGCCTAATCTTGACCC, mouse GM3S; (59-39)
ATGCCAAGTGAGTTCACCTCT (39-59) GTGCAAC-
CAACGTAAACCTCA, human GAPDH; (59-39) TTCCATGG-
CACCGTCAA (39-59) ACTCATGCAGCACCTCAGGT, mouse
GAPDH; (59-39) ACTTTGTCAAGCTCATTTCC (39-59)
GTAGTTATTTCAAGCGACGT. The PCR was performed in
triplicate on cDNA samples using SYBR Green Master Mix
(Finzymes) according to the manufacturer’s protocol. GM3
synthase gene expression levels were normalized to those of
glyceraldehyde 3-phosphate dehydrogenase in each sample.
Mass Spectrometry
GSLs were extracted from human synovium. GSL glycans were
digested by enzymatic reaction employing GSL-specific endogly-
coceramidases II (EGCase II) derived from mutant strain M-750
of Rhodococcus sp. (TAKARA Bio). The solutions treated with
EGCase II were subjected to glycoblotting using a protocol similar
to that used for N-glycome analyses reported previously [35]. The
samples were analyzed by Matrix Assisted Laser Desorption
Ionization - Time of Flight (TOF) MS on an Ultraflex II TOF/
TOF mass spectrometer (Bruker Daltonics) equipped with a re-
flector, and controlled by the FlexControl 3.0 software package
(Bruker Daltonics). Peaks were detected as proton-adducted ions.
Masses were annotated using the FlexAnalysis 3.0 software
package (Bruker Daltonics). In addition to the TOF/TOF
analyses, we used the GlycoSuiteDB (http://glycosuitedb.expasy.
org/glycosuite/glycodb) and SphinGOMAP
 (http://www.
sphingomap.org/) databases to identify the glycan structures.
Collagen-induced Arthritis
CIA was induced in C57BL/6-background WT or GM3S
2/2
mice as described previously [36]. Briefly, CIA was induced using
an emulsion comprising equal amounts of Complete Freund’s
Adjuvant (CFA) containing 5 mg/ml heat-killed Mycobacterium
tuberculosis (Chondrex) and chick type II collagen (CII) solubilized
at 2 mg/ml in 0.05 M acetic acid (Chondrex). The mice were
immunized with 100 ml of emulsion (100 mg chick CII) in-
tradermally at several sites at the base of the tail. After 21 days
of primary immunization, the mice received intradermal boosters
with a volume of emulsion equal to that of the primary
immunization near the primary injection sites.
Clinical Assessment of Arthritis
The mice were examined daily for clinical symptoms of arthritis,
and a mean arthritis score was calculated as described previously
[37]: score 0, normal; score 1, redness and/or swelling in one joint;
score 2, redness and/or swelling in more than one joint; score 3,
redness and/or swelling of the entire paw; score 4, deformity and/
or ankylosis.
Histological Assessment of Arthritis
For histological examination of joints, mice were anesthetized
and killed at day 35 after primary immunization. The right hind
paw was dissected and placed in 10% buffered formalin and
decalcified in 10% EDTA, pH 7.5, for 1 week. These tissues were
then dehydrated in an ascending series of ethanol, the tissues were
embedded in paraffin, sectioned, and stained with hematoxylin
and eosin (HE). Sections were assessed using a separate histological
score of 0 (normal), 1 (mild), 2 (moderate), or 3 (severe) for
inflammation, synovial hypertrophy, cartilage damage, and bone
destruction [38]. Human synovial tissues were obtained from
patients with total knee arthroplasty and immediately embedded
in Optimal Cutting Temperature (OCT) compound for frozen
sections. Sections (5 mm thick) were cut from frozen tissue samples,
fixed in acetone, air-dried and used for HE staining.
Measurement of Total and Anti-CII IgG Antibodies
Blood samples were obtained from the orbital sinus and allowed
to clot at room temperature for 1 h. Individual sera were
measured for total and anti-CII antibodies (IgG1, IgG2a, IgG2b,
and IgG3) on day 35 after primary immunization using an
enzyme-linked immunosorbent assay (ELISA) kit (Chondrex)
according to the manufacturer’s instructions.
Flow Cytometric Analysis
We collected iLN from C57BL/6 mice on day 7 after
immunization with CII-CFA. Cells were washed and blocked
with 1 mg/ml of Fcc blocker (BD Pharmingen). After washing, to
The Role of GM3 in Rheumatoid Arthritis
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incubated with the indicated fluorescein isothiocyanate (FITC)-,
phycoerythrin (PE)-, and allophycocyanin-conjugated antibodies
(0.5 mg for 30 min) to stain for CD3, CD4, CD8, CD11b, and
B220.
For investigating the ratio of Th17 cells in CD4
+ T cells, iLN
cells were incubated for 5.5 h with phorbol myristate acetate
(20 ng/ml), ionomycin (250 ng/ml), and brefeldin A (1 ml/ml;
GolgiPlug; BD Biosciences). Cells were washed and blocked with
1 mg/ml Fcc blocker (BD Pharmingen) before extracellular
staining for CD3 and CD4. Cells were then fixed and
permeabilized with BD Cytofix/Cytoperm (BD Bioscience) and
stained intracellularly for IL-17 or IFNc. Flow cytometric analysis
was performed with FACS Caliber (BD, Mountain View) and
Flowjo software (TREESTER). We used the following antibodies:
FITC-conjugated anti-CD3 antibody (BioLegend), PE-conjugated
anti-CD4 antibody (BioLegend), APC-conjugated anti-CD8a
antibody (Pharmingen) PE-conjugated anti-B220 antibody (Bio-
Legend), FITC-conjugated anti-CD11b antibody (BD Pharmin-
gen), PE-conjugated anti-IFNc antibody (BD Pharmingen), and
allophycocyanin-conjugated anti-IL-17 antibody (BioLegend).
Response of T Cells with Anti-CD3 Antibody in vivo
Individual mice were intraperitoneally administered 20 mg anti-
CD3 antibody. Serum was collected 1.5 h later and IL-17, IL-4,
IFNc, TNFa, IL-6 levels were measured using ELISA kits (R&D
Systems) according to the manufacturer’s instructions.
Statistical Analysis
Data are expressed as mean 6 SEM. Differences between
groups were analyzed by Mann-Whitney U test, except cumulative
incidence was evaluated with a x
2 test. A P value of less than 0.05
was considered statistically significant.
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